Hangzhou Diagens Biotechnology Co Ltd (HKSE:02526) Share Price

Company Profile

Business description
Hangzhou Diagens Biotechnology Co Ltd is a medical devices company focusing on developing medical imaging products and services. It has self-developed a diversified portfolio, including six medical imaging software products, three commercialized medical devices, four key reagents and consumables and two technology licensing offerings. Its Core Product, AI AutoVision, is an auxiliary diagnostic software designed to undertake intelligent analysis on chromosome karyotyping which the company intends to sell in China and globally as a customized computer pre-installed with the software.
Contact
No. 609 Hongfeng Road
Room 101, Building 1
Donghu Sub-district
Linping District, Zhejiang
Hangzhou
CHN
T: +86 4000680888
https://www.diagens.com
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2026
Employees
182

Recommended

Microsoft’s earnings report is expected to touch on AI adoption and monetization.

Dan Romanoff, CPA | 23 April 2026

The ongoing war is likely to keep commodity prices even more volatile than usual until it is resolved.

Jon Mills, CFA | 23 April 2026

How investors can uncover value beyond the index heavyweights.

Tyger Fitzpatrick | 23 April 2026

Index	Last price	Change	% Change
All Ordinaries	9,024.20	27.20	-0.30%
CAC 40	8,156.43	79.28	-0.96%
DAX 40	24,194.90	75.97	-0.31%
Dow JONES (US)	49,490.03	340.65	0.69%
FTSE 100	10,476.46	21.63	-0.21%
HKSE	25,924.54	238.70	-0.91%
NASDAQ	24,657.57	397.60	1.64%
Nikkei 225	59,140.23	445.63	-0.75%
NZX 50 Index	12,884.93	60.67	-0.47%
S&P 500	7,137.90	73.89	1.05%
S&P/ASX 200	8,793.40	26.10	-0.30%
SSE Composite Index	4,087.08	19.18	-0.47%